A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis
Open Access
- 1 November 2019
- journal article
- research article
- Published by Becaris Publishing Limited in Journal of Comparative Effectiveness Research
- Vol. 8 (15) , 1265-1298
Abstract
Aim: Indirect treatment comparisons are used when no direct comparison is available. Comparison networks should satisfy the transitivity assumption, that is, equal likelihood of treatment assignment for a given patient based on comparability of studies. Materials & methods: Seven criteria were evaluated across 18 randomized controlled trials in psoriatic arthritis: inclusion/exclusion criteria, clinical trial design and follow-up, patient-level baseline characteristics, disease severity, prior therapies, concomitant and extended-trial treatment and placebo response differences. Results: Across studies, placebo was a common comparator, and key efficacy end points were reported. Collectively, several potential sources of insufficient transitivity were identified, most often related to trial design and population differences. Conclusion: Potential challenges in satisfying transitivity occur frequently and should be evaluated thoroughly.Keywords
This publication has 50 references indexed in Scilit:
- Graphical Tools for Network Meta-Analysis in STATAPLOS ONE, 2013
- Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomingsAnnals of the Rheumatic Diseases, 2013
- Smoking and delay to diagnosis are associated with poorer functional outcome in psoriatic arthritisAnnals of the Rheumatic Diseases, 2013
- Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trialThe Lancet, 2013
- Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiersBMC Medicine, 2013
- Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics?Pharmacoepidemiology and Drug Safety, 2012
- A randomized placebo-controlled trial of methotrexate in psoriatic arthritisRheumatology, 2012
- Indirect Comparisons: A Review of Reporting and Methodological QualityPLOS ONE, 2010
- Different Methods of Balancing Covariates Leading to Different Effect Estimates in the Presence of Effect ModificationAmerican Journal of Epidemiology, 2009
- Use of Indirect and Mixed Treatment Comparisons for Technology AssessmentPharmacoEconomics, 2008